Orpro Therapeutics Inc
OrPro Therapeutics Inc., based in Dover, DE, is focused on developing the Theradux non-systemic biologic drug platform aimed at treating diseases of the lung and other epithelial surfaces plagued by chronic infection, inflammation, and obstructive mucus. Their research includes advancements related to cystic fibrosis and novel therapies for respiratory complications associated with COVID-19.
The company is actively engaged in creating ORP100S, a biologic therapy designed to alleviate inflammation and obstruction in the lungs, particularly in patients suffering from chronic airway disorders and severe COVID-19 consequences stemming from SARS-CoV-2 infection. OrPro Therapeutics is positioned at the forefront of innovative solutions for respiratory health challenges.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.


